Pharmion

company

About

Pharmion engages in the acquisition, development, and commercialization of products for the treatment of hematology and oncology patients.

  • 501 - 1000

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$65M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1999
Number Of Employee
501 - 1000
Operating Status
Active

Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to identify and develop products for global hematology and oncology markets.

To expand each product's potential, we have established our own regulatory, development and sales and marketing organizations in the United States, Europe, and Australia, and we have developed a third-party distributor network to serve the hematology and oncology markets in 20 additional countries throughout the Middle East, Asia, and Latin America. The global capabilities within our sales, marketing and distribution organization distinguishes us from other companies of a similar size. With our international network we can reach physicians and their patients in more than 30 countries.

With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on licensing, developing, and commercializing therapeutic products for the treatment of hematology and oncology patients. Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients’ quality of life.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$105M
Pharmion has raised a total of $105M in funding over 2 rounds. Their latest funding was raised on Oct 16, 2002 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 16, 2002 Series Unknown $40M 2 Detail
Dec 14, 2001 Series Unknown $65M 2 Nomura International Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Pharmion is funded by 2 investors. Nomura International and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nomura International Series Unknown
Versant Ventures Series Unknown